Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06584448 · ClinicalTrials.gov registry record · NA
Drinking, Acetate, and Stress
A NA study of Alcohol Use Disorder and Alcohol Use, Unspecified, sponsored by Yale University.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 2
- Study locations
NCT06584448 is a NA study of Alcohol Use Disorder and Alcohol Use, Unspecified that is actively recruiting participants, run by Yale University. The registered enrollment target is 50 participants, below the 328-participant average among 184 other Alcohol Use Disorder trials with a reported enrollment target (85% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT06584448, a NA study of Alcohol Use Disorder and Alcohol Use, Unspecified, is actively recruiting participants, sponsored by Yale University.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to learn how drinking alcohol affects how people experience stress and how that is affected by the body's chemistry. Specifically, the investigators will be studying relationships of drinking and a stress hormone called cortisol. The investigators believe that results will lead us to find more effective ways to help people stop or reduce drinking when participants are drinking at harmful levels.
Conditions Studied
Interventions
- OTHER Deuterium Metabolic Imaging with deuterated acetate tracer
Study Locations (2)
Connecticut
- The Anlyan Center, 300 Cedar St. - New Haven
- Yale University - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2024-11-06 |
| Est. Completion | 2030-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06584448
The ClinicalTrials.gov registry entry for NCT06584448 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 328-participant average among 184 other Alcohol Use Disorder trials with a reported enrollment target (85% lower). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Alcohol Use Disorder appearing as the primary indexed condition, and to 1 intervention - of which Deuterium Metabolic Imaging with deuterated acetate tracer is the first listed.
NCT06584448 reports 2 study locations spanning 1 distinct geographic area - top geographies include Connecticut.
Frequently Asked Questions
What is clinical trial NCT06584448 about?
NCT06584448 is a clinical study titled "Drinking, Acetate, and Stress". The purpose of this study is to learn how drinking alcohol affects how people experience stress and how that is affected by the body's chemistry. Specifically, the investigators will be studying relationships of drinking and a stress hormone called cortisol. The investigators believe that results wi...
What is the current status of trial NCT06584448?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2024-11-06. Estimated completion is 2030-01.
What conditions does trial NCT06584448 study?
This clinical trial studies the following conditions: Alcohol Use Disorder, Alcohol Use, Unspecified, Heavy Drinker, Alcohol Use Disorder, Moderate, in Sustained Remission.
What interventions are being tested in trial NCT06584448?
The interventions under investigation include: Deuterium Metabolic Imaging with deuterated acetate tracer (OTHER).
Who is sponsoring clinical trial NCT06584448?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06584448 being conducted?
This trial has 2 study locations across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alcohol Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Ultrasound Neuromodulation of the Brain for Alcohol Use Disorder
RECRUITING · NA
-
TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk
RECRUITING · NA
-
Integrated Treatment for Enhancing Growth in Recovery During Adolescence
RECRUITING · NA
-
AAT for Alcohol Use Disorder in Veterans
RECRUITING · NA
-
Testing a PTSD m-Health Intervention to Improve Alcohol Treatment Outcomes
RECRUITING · NA
-
Validating an Autonomous Interactive Internet-Based Delivery of an Empirically Supported Cognitive Behavioral Therapy for Comorbidity
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.